Remove 2018 Remove Medical director Remove Palliate Remove Presentation
article thumbnail

Hospices Need a ’Huge Catapult’ to Replenish Workforce

Hospice News

This can result in patients coming to hospice later in the course of their illnesses, according to Lee, who also serves on the board of directors at the Social Work Hospice & Palliative Care Network (SWHPN). Most students in clinical disciplines do not feel prepared to provide family care at the end of life, according to a 2018 study.

Hospice 276
article thumbnail

5 Numbers that Shaped Hospice in 2022

Hospice News

Executives from almost every publicly traded hospice company raised this issue in earnings calls and presentations throughout the year. Social workers saw an average 4.07% hourly wage hike, and medical directors saw the lowest rate of increase at 0.6%, the report indicated. The shortage isn’t going away.

2022 196
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

By 2007, the Washington State Agency Medical Directors Group (AMDG), which included several eventual PROP members (23), published an “Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain (26) that introduced the concept of hard dosing thresholds for opioid analgesics, which was later incorporated into the 2016 Guideline (2, 3).

2016 145
article thumbnail

Roger Chou’s Undisclosed Conflicts of Interest: How the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain Lost Its Clinical and Professional Integrity

Pallimed

Lewis PhD, Beverly Schechtman and Carrie Judy “I'm present. Franklin also served on the Washington State Agency Medical Directors Group (AMDG) via the Washington State Department of Labor and Industries (9). Kollas MD, Terri A. Uh … I do have a conflict. They had reviewed potential nonfinancial conflicts carefully (e.g.,

2016 89
article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

There is a lot to digest with these draft clinical guidelines but the big change from the 2018 guideline is moving Alzheimers to a biological diagnosis (biomarker evidence only) not just for a research framework but now from a clinical one. Welcome back to GeriPal podcast, Sharon. Sharon: Thank you for having me again.